Multaq and Codeine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Multaq (dronedarone hydrochloride) and Codeine (codeine sulfate). Common drug interactions include drug hypersensitivity among females and hepatic vein thrombosis among males.

The phase IV clinical study analyzes what interactions people have when they take Multaq and Codeine. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Multaq?

Multaq has active ingredients of dronedarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 11,053 Multaq users. Check the latest studies of Multaq.

What is Codeine?

Codeine has active ingredients of codeine sulfate. It is often used in pain. eHealthMe is studying from 42,342 Codeine users. Check the latest studies of Codeine.

On Jul, 22, 2026

15 people who take Multaq and Codeine together, and have interactions are studied.

What are the common drug interactions of Multaq and Codeine, by gender? *:

female:

Drug hypersensitivity
Fatigue (feeling of tiredness)
Herpes zoster
Stress
Weight decreased
Abdominal distension
Chronic kidney disease
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Generalised oedema (swelling all over the body)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

male:

Hepatic vein thrombosis (obstruction in the veins of the liver caused by a blood clot)
Hypoxia (low oxygen in tissues)
Blood calcium increased
Blood creatinine increased
Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Death
Drug hypersensitivity
Fear
Fistula (an abnormal connection or passageway between two)
Haematoma (collection of blood outside the blood vessels)

What are the common drug interactions of Multaq and Codeine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal distension
Generalised oedema (swelling all over the body)

50-59:

Death

60+:

Drug hypersensitivity
Hepatic vein thrombosis (obstruction in the veins of the liver caused by a blood clot)
Fatigue (feeling of tiredness)
Herpes zoster
Stress
Weight decreased
Abscess intestinal (collections of pus-intestinal)
Blood calcium increased
Blood creatinine increased
Chronic kidney disease

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 1 person, 6.67%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 1 person, 6.67%
High Blood Pressure: 1 person, 6.67%
Headache (pain in head): 1 person, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%
Diarrhea: 1 person, 6.67%
Acne (skin problems that cause pimples): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Multaq and Codeine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously